TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive A “Screw-Up” Worked in MD Anderson’s Favor In Seven-Year Stint as U.S. News & World Report Top-Ranked Cancer Center July 19, 2013
TCL Archive DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million February 27, 1987